Report of the 2007 Annual Survey

Slides:



Advertisements
Similar presentations
© 2013 The McGraw-Hill Companies, Inc. All rights reserved Medical and Surgical Section Coding guideline B2.1a. – Procedure codes in the general.
Advertisements

Working together, making a difference every day POPS Project Organ and Tissue Donation.
Michigan Health & Hospital Association and Gift of Life Michigan Welcome to the MHA Keystone: Gift of Life Webinar Wednesday, September 19, :00 pm.
Report of the 2007 Annual Survey AATB-accredited Tissue Banks in Canada.
1 Donate Life An Introduction to Organ and Tissue Donation.
Donate Life An Introduction to Organ and Tissue Donation.
Diane Wilson, RN Community Tissue Services
Is Nucleic Acid Testing for Organ Donors the ‘Right’ Choice? Reference: Humara A, Morrisb M, Blumbergc R, et al. Nucleic acid testing (NAT) of organ donors:
FDA Basics: Tissue Safety
Organ Transplantation. Transplant History Skin grafts – possibly as early as 2 nd century 1 st confirmed skin graft – 16 th century Tissue transplants.
Organ Donation 9.PCH.1.2: Summarize the procedures for organ donation, local and state resources, and benefits.
9.PCH.1.2 Summarize the procedures for organ donation, local and state resources, and benefits.
ORGAN DONATION Warm-Up # 1.What do you already know about organ donation? 2.Why do you think someone would say “no” to organ donation?
 A heart on a NC driver’s license indicates you want to be a donor  It is illegal to buy or sell organs and tissues for transplantation in the United.
The Need: What’s Being Transplanted? n Organs: –in adults & children with end- stage organ failure –Heart –Heart-Lung –Lung n single or double –Liver.
ORGAN DONATION By: Aubree Malone. “When you’re not an organ donor when you die, you’re taking a lot of people with you.”
Top 5 OPTN Policy Violations
Department of Computer Science Stony Brook University
From Donor A Second Chance for Sight “ With the transplant I am able to play sports in high school and I hope to continue to play in college. I am forever.
Managing Pre-Hospital Exposures PRODUCED BY RI Department of Health, Division of EMS & Hospital Association of Rhode Island.
PHS GUIDELINE FOR REDUCING TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS, HEPATITIS B VIRUS AND HEPATITIS C VIRUS THROUGH SOLID ORGAN TRANSPLANTATION ACOT.
The Importance of Organ, Eye and Tissue Donation.
HEART DISEASE SBI 3C: DECEMBER HEART ATTACK:  Blood flow to a section of the heart is blocked  If oxygen cannot get through the muscle starts.
Name Title Company. 2 At the end of the presentation the learner will: Have an understanding of the donation process Be able to verbalize which organs.
Organ Donation. Over 106,000 Americans are on transplant waiting lists (4,500 in NJ) In 1988, 4,080 people donated organs after death. In 2008, that number.
ABOUT NEVADA DONOR NETWORK Federally designated, 501 (c)(3) not-for-profit Organ Procurement Organization (OPO) Coordinate, recover, and distribute donated.
 The Uniform Anatomical Gift Act allows a consenting individual to donate his or her organs and tissues upon death for the purpose of transplantation.
Exploring the Risks of Contaminated Medical Products MODERATOR: Susan R. Chmieleski, APRN, CPHRM, FASHRM, JD, Senior Vice President, Healthcare Product.
Organ & Tissue Transplants
Field Office Staff Presentation DMV and Oregon’s DONOR REGISTRY Extending the Power to Donate Life.
2011 ORGAN DONATION CONGRESS
KY ORGAN DONOR AFFILIATES. Organ donation may occur in brain death situations, allowing a person to donate kidneys, lungs, heart, liver, pancreas and.
1 ‘Part of the healing:’ Mom tracks impact of organs donated from 6-day-old son Originally published April 5, 2015 at 4:35 pm Within hours of Thomas’ death,
Minimizing the Risks of TSE Agents in Human Tissues Melissa A. Greenwald, M.D. Division of Human Tissues Office of Cellular, Tissue and Gene Therapies;
Obj: I will investigate the procedures for organ donation and the benefit to society.
By Dr.(Mrs.)Mosunmade Faderin-Omotosho Medical Director Eye Bank for Restoring Sight, Nigeria.
Organ / Tissue / Eye Donation Overview Essential Information for Health Care Professionals.
1 Infectious Disease Verification to Enhance Patient Safety Operations and Safety Committee.
SHRI V. N. GOVT. MEDICAL COLLEGE, YAVATMAL
Organ & Tissue Donation
Organ Donor.
Objectives Upon completion of this training, agencies will be able to:
Organ Transplant Process
UW Hospital and Clinics Organ Procurement Organization (OPO)
Musculoskeletal system
Medical Examiner Referral System
© Copyright Cengage Learning 2015 Chapter 10 Autopsy Rates.
Organ, Eye and Tissue Donation in New York
Levels Of Organization
C-SCOPE: Survey on the Management of HCV in addiction clinics treating Patients on Opiate Agonist Therapies: a global perspective July 2017.
Levels Of Organization
Clarify Informed Consent of Transmittable Conditions
Organ Donation 9.PCH.1.2: Summarize the procedures for organ donation, local and state resources, and benefits.
Clarify Informed Consent of Transmittable Conditions
Levels Of Organization
One Legacy Organ Donation
Organ and Tissue Donation and Transplantation
Musculoskeletal System
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
Levels Of Organization
Organ Transplantation
Introduction To Medical Technology
Public Health Surveillance
Levels Of Organization
Skull flaps: autologous tissue
Clarify Informed Consent of Transmittable Conditions
Vascularized Composite Allograft (VCA) Transplantation Committee
Levels Of Organization
SUNNYBROOK TRANSFUSION MEDICINE AND TISSUE BANK
Be an organ, eye and tissue donor.
Presentation transcript:

Report of the 2007 Annual Survey AATB-accredited Tissue Banks in the United States

When referencing information or data from this presentation, use the following citation: 2007 American Association of Tissue Banks (AATB) Annual Survey of Accredited Tissue Banks in the United States.  McLean, VA: AATB, 2010.

Managed by © In-Touch Survey Systems, Inc.

116 Survey Participants 7 AATB-accredited tissue banks in Canada All data is maintained in a separate report 109 tissue banks in the United States 82 are AATB-accredited (75%) 27 are not accredited by AATB (25%; all “recover”) 77 “recover” (71%) 5 completed the Recovery Section of the survey but functions may only include receiving referrals and performing some screening, and possibly obtaining consent (does not include recovery of tissue) 63 store (58%) 32 process (29%) 52 distribute (48%) This survey did not solicit participation from the AATB-accredited Reproductive Tissue Banks or Non-Transplant Anatomical Donation Organizations.

Was your tissue bank inspected in 2007? Yes = 88 (81%)

29 (27%) were inspected by a State agency Inspected by whom? 59 of 109 (54%) 36 of 82 (44%) 29 (27%) were inspected by a State agency

Inspected by “Others”

“Recovery” (includes referral, screening, consent, &/or recovery)

Recovery Section Data Landmark survey: participation by both AATB-accredited tissue banks and those not AATB-accredited 55 are accredited by AATB 27 are not accredited by AATB 5 perform functions leading up to, but not including, tissue recovery 77 tissue banks recovered tissue

Recovery How many tissue donors did your Tissue Bank recover for transplantation? = 30,380 Deceased = 29,799 (98%) How many had an autopsy performed? 27% Living = 581 (2%) How many tissue donors were also organ donors? 9% How many tissue donors were also ocular donors? 27%

Average 395 Donors/Tissue Bank; 7 Tissue Banks exceeded 1,000 Donor recoveries; Most recovered by one Tissue Bank= 1,438 Donors

Deceased Donors Tissue Type # of Donors # of Tissue Banks % of Tissue Banks that Recover Tissue Musculoskeletal (bone, cartilage , OA) 25,157 72 94 Soft Tissue (fascia, ligaments, tendons, pericardium, dura, nerves) 21,157 69 90 Skin (thin, thick, full thickness) 19,854 71 92 Cardiac (heart for valves, thoracic aorta) 7,216 74 96 Vascular (veins, arteries) 5,153 62 81 Vertebral Bodies 75 2 3

Deceased Donors Tissue Type* # of Donors Recovered by AATB -accredited TBs # of Donors Recovered by TBs not accredited by AATB Musculoskeletal (bone, cartilage , OA) 19,761 8,012 Soft Tissue (fascia, ligaments, tendons, pericardium, dura, nerves) 14,341 4,848 Skin (thin, thick, full thickness) 13,240 4,691 Cardiac (heart for valves, thoracic aorta) 4,999 2,274 Vascular (veins, arteries) 4,263 1,690 * these definitions are used throughout the survey

# of Donor Recoveries by Type

Sites of Recovery - Deceased Donors % Heath Care Facility Operating Room 51.3 Dedicated Tissue Recovery Suite 22.7 Medical Examiner Office (Dedicated Room) 9.4 Hospital Morgue 9 Funeral Home 5.4 (Open Autopsy Room) 2.1 Other 0.1

Sites of Recovery - Deceased Donors % in 2003 survey % in 2007 Change Heath Care Facility Operating Room 46.1 51.3 Up Dedicated Tissue Recovery Suite 19.4 22.7 Medical Examiner Office (Dedicated Room) 9.6 9.4 Same Hospital Morgue 15.6 9 Down Funeral Home 6.2 5.4 (Open Autopsy Room) 2.1 Other 0.9 0.1

# of all Tissue Donors (#s reported are for only 29,358 of 30,380 donors)

Multiple Tissues Recovered/Tissue Bank

Recovery - Skin Skin Donors Full-Thickness = 8,616 (from 31 Tissue Banks) Thin = 8,223 (from 39 Tissue Banks) Thick = 1,092 (from 12 Tissue Banks) More than one skin type can be recovered from a donor but double-reporting expected to be low.

Referral - All Donation Source # of Referrals % Hospital 744,212 96.32 ME/Coroner 15,110 1.96 ECF/NH/Hospice 4,080 0.53 An OPO 3,029 0.39 Funeral Home 2,286 0.30 An Eye Bank 1,684 0.22 Other 1,300 0.17 First Responders 541 0.07 Law Enforcement 213 0.03 Another Tissue Bank 93 0.01 Home 84

“Consent” - All Donation Approaches 114,173 Obtained 33,604 1st P/Donor Designation/Registry 6,411 NOK or Other Consenting Person 24,418 Denied 73,484 Unsuccessful - NOK Unavailable 11,974 Consent Obtained, No Recovery 13,595 The “average Tissue Bank” makes 1,784 approaches for consent and 64% of those are denied. It obtains 601 consents and two thirds of those result in recovery.

“Consent” - All Donation Successful Consents Obtained by: % Tissue Bank Personnel 45 OPO Personnel 33.4 Designated Screening/Consent Service 11.2 Hospital Personnel 9.1 Other 1.3 〉 Combine for 78% of all successful consents Information was not available for 12 Tissue Banks, 8 of which are accredited by AATB.

Ineligible During Screening (Prior to going on site for recovery) Prevalence Reason % 1 Age 43.3 2 Medical Hx 41.4 3 “Other” (many list Medical Examiner restrictions here) 8.7 4 Behavioral Risk Hx 2.5 5 Time Restrictions 1.8 6 Infectious Disease Testing 1.3 7 Plasma Dilution 0.6 8 Trauma 0.5

Determined Ineligible at Site of Recovery Prevalence Reason % 1 Physical findings 36.6 2 Chart findings 25.4 3 Logistics (e.g., insufficient body cooling, time expired, body no longer available, etc.) 19.8 4 Related to blood sample (e.g., plasma dilution, no sample available) 9.5 5 Other 8.8

Determined Ineligible After Recovery Prevalence Reason % 1 Infectious Disease Testing 39.1 2 Pre-processing Cultures 23.8 3 Medical Hx 18.7 4 Other 7.5 5 Autopsy Results 7.1 6 Behavioral Risk Hx 3.7 7 Tissue Quality 1.7 A few donors may have more than one reason for an ineligible determination.

Processing

Processing # of Tissue Banks = 32 Total donors processed = 49,207 Process bone (MS) = 24 Process soft tissue (ST) = 20 Process skin = 14 Process cardiac/vascular (C & V)= 4 Process tissue devices = 8 Process tissue from Living Donors = 7 Total donors processed = 49,207 4 Tissue Banks each processed >4,000 donors Average graft yield per donor = 49

Tissue Banks - Specialization of Processing Services

Processing # of Musculoskeletal Donors = 23,466 Bone = 19,370 Cartilage = 267 Osteoarticular (fresh) = 594 Osteoarticular (frozen) = 1,271

Processing # of Soft Tissue Donors = 20,578 Tendons = 12,120 Ligaments = 8,635 Fascia = 7,580 Pericardium = 5,090 Nerves = 49 Dura = 12

Processing Cardiac + Vascular Donors = 8,826 Heart Valves = 7,026 Non-valved conduits = 4,492 Veins = 4,312 Arteries = 1,705

Processing # of Skin Donors = 17,120 # of Tissue Banks Thin = 8,335 Full-Thickness = 4,767 Thick = 3,392 # of Tissue Banks Processing skin = 14 Provide fresh skin = 5

Use of Radiation ≈ 10% treat tissues with radiation prior to processing and treatment is usually Gamma radiation below 1.5 Mrads (or 15 kGy) ≈ 53% treat tissues with radiation as a final treatment. Gamma radiation is type most commonly used and target dose is 1.5-2.5 Mrads 8 tissue banks use radiation to treat allografts 6 of 24 process Musculoskeletal tissue 8 of 20 process Soft Tissue

“E-beam only” also reported by 2 tissue banks: Treatment Methods Antibiotics only MS - 5 tissue banks processed ≈ 118,000 grafts ST - 3 tissue banks processed ≈ 3,600 grafts Antibiotics + Gamma radiation MS - 4 tissue banks processed >158,000 grafts ST - 3 tissue banks processed ≈ 16,000 grafts Proprietary method only MS - 10 tissue banks processed ≈ 760,000 grafts ST - 9 tissue banks processed ≈ 38,000 grafts Proprietary method + Gamma radiation MS - 6 tissue banks processed >588,000 grafts ST - 8 tissue banks processed ≈ 58,000 grafts “E-beam only” also reported by 2 tissue banks: MS ≈ 86,000 ST ≈ 950 ******************

Treatment Methods

Demineralized Bone Matrix (DBM) 15 Tissue Banks process DBM Reported applications: 43.8% dental/periodontal 43.8% orthopaedics 25% neurosurgery 3.1% “other”

Processors Reporting Recovery

Infectious Disease Testing

Infectious Disease Testing % RR % Confirmed Positive* HBsAg 0.59 4.69 HBcAb (total) 2.54 HBV NAT 0.47 HCV Ab 1.01 13.86 HCV NAT 0.69 HIV 1/2 Ab 0.18 1.72 HIV-1 NAT 0.23 HIV-1/HCV NAT 0.42 HTLV I/II Ab 0.31 3.09 Syphilis 0.34 7.31 WNV NAT 0.27 CMV Ab 47.1 † † Total number of “donors tested” varies from test to test but was generally ≈ 49,000 per required test. Duplicate reporting is expected since total donors recovered = 30,380 (living + deceased) * Not all tissue banks perform confirmatory testing. Of those who did, these %s are from their experience.

Distribution

2,110,200 tissue grafts reported as distributed by these Tissue Banks; some duplicate reporting occurs with redistributed grafts by intermediaries accredited by AATB. 4 more TBs distribute but failed to report #s. These #s are not large but will be rectified in future reports.

Distribution (tissue from deceased donations) Grafts sent to: # * Hospital/Medical Facilities 933,200 Tissue Distribution Intermediaries 514,900 Doctors/Dentists 446,594 Another Tissue Bank 33,851 Other (mostly to a contract manufacturing establishment) 32,298 1,960,843 *all #s adjusted for grafts reported to be (re) distributed by an intermediary (not a processor). It is not known if ALL grafts distributed by intermediaries originate from AATB-accredited processing tissue banks.

Distribution (tissue from deceased donations) Graft type # of grafts reported* Musculoskeletal 1,166,968 Tissue Devices 501,449 Skin 312,189 (>28,958 sq ft) Soft Tissue 152,082 Cardiac 5,349 Vascular 3,592 Dura 331 2,141,960 *all #s adjusted for grafts reported to be (re) distributed by an intermediary (not a processor). It is not known if ALL grafts distributed by intermediaries originate from AATB-accredited processing tissue banks.

Musculoskeletal Distribution (From Deceased Donations - #s not adjusted) “Other” reported erroneously by 15 Tissue Banks & contained mostly cortical, demin cortical, FH/HH, and traditional spine

Soft Tissue Distribution (From Deceased Donations - #s not adjusted) “Other” reported as ‘devices,’ sclera, or (erroneously) patellar tendons

© Matthiashaas | Dreamstime.com International Tissue grafts/devices are distributed to 45 countries outside the US 29 (56%) of 52 US Tissue Banks distribute to other countries © Matthiashaas | Dreamstime.com

Implant Card Return Experience % Returned % of Tissue Banks 0 - 25% 6% 26 - 50% 21% 51 - 75% 43% 76 - 100% 30% 47 Tissue Banks reporting, of which 18 report actual, tracked information.

Send inquiries to brubakers@aatb.org